FdaApplication
NDA 211723
Identifiers
- fda_app_no: NDA211723
Properties
| Property | Value |
|---|---|
| applicant_name | EPIZYME INC |
| application_type | NDA |
| approval_date | 2020-01-23 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| TAZVERIK | TAZEMETOSTAT HYDROBROMIDE | EQ 200MG BASE | TABLET;ORAL |
1 product